APEMM - Association de Prévention et d'Etudes des Maladies Moléculaires qui soutient les chercheurs qui développent des thérapies innovantes pour soigner les maladies moléculaires.
La société BERTHOLD FRANCE SAS basée à Thoiry dans les Yvelines regroupe les activités de vente et de service après-vente d'appareils destinés à la recherche scientifique, médicale ainsi qu'à l'industrie.
The Society is a charity with a mission to promote and advance the whole spectrum of pharmacology, and leads the way in the research and application of pharmacology around the world. Connecting over 4,000 members from more than 60 countries, it is a global community at the heart of pharmacology.
CALIXAR offers a unique and patented technological platform allowing to isolate in solution – with the highest purity levels – full-length membrane proteins, while keeping their structural and functional integrity.
The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public.
Domain Therapeutics, a French and Canadian privately-held biopharmaceutical company, is using transmembrane and G Protein-Coupled Receptor (GPCR) targeting for the discovery and development of innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer.
Reconnue d’utilité publique, la Fondation ARC est 100 % dédiée à la recherche sur le cancer. Grâce à la générosité de ses donateurs et testateurs, elle alloue chaque année plus de 25 millions d'euros à des projets de recherche porteurs d'espoir pour les malades.
The Esteve Foundation was established in 1983 with the primary goal of fostering progress in pharmacotherapy by ways of scientific communication and discussion.
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.
Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.
InterAx is a Swiss Biotech company spinoff from the ETH Zürich and Paul Scherrer Institute.
InterAx assists drug candidate design and selection with its unique and novel systems biology platform. This technology allows for the integration of both, experimental and computational pharmacology, and is able to predict in vivo effects of drug candidates by analyzing complex experimental in vitro data sets. Currently, the InterAx technology is applicable to all drug discovery programs on G protein-coupled receptors (GPCRs).
Le projet CheMISyst du Pôle Balard, centré sur la Chimie des systèmes moléculaires et interfaciaux, bénéficie d’une puissante dynamique initiée depuis plusieurs années.
Vous avez une question à nous poser ? Nous sommes là pour vous aider ! Utilisez le moteur de recherche ou contactez-nous directement par téléphone, email, ou en localisant le Comité départemental de la Ligue le plus proche de chez vous. Créez votre espace pour obtenir des contenus personnalisés et rejoignez notre communauté afin d’exprimer votre avis, votre ressenti, vos idées.
Multispan, Inc. is a premier assay screening technology provider focusing primarily on cellular drug discovery research targeting GPCRs and beyond. It has created the industry’s largest, highly characterized, high quality GPCR-expressing stable cell lines. The assay platform enables HTS and lead optimization applications in new drug discovery programs to treat cardiovascular, metabolic, neurodegenerative, depression, inflammation, immunology and oncology diseases.
Le projet MUSE « Montpellier Université d’Excellence » mobilise les forces de 19 institutions vers une ambition commune : faire émerger à Montpellier une université thématique de recherche intensive, internationalement reconnue pour son impact dans les domaines liés à l’agriculture, l’environnement et la santé, susceptible de devenir pour tous les membres du consortium un partenaire académique auquel ils seront fortement liés et dont ils pourront se prévaloir.
Our mission of innovating for a healthier world is at the heart of everything we do. We help customers make smarter decisions, earlier diagnoses, more effective treatments and scientific breakthroughs.
La Société Française de Biophysique a pour objectifs de :
promouvoir le développement et d'assurer la diffusion de la Biophysique en tant que discipline scientifique.
fédérer la communauté des biophysiciens et la représenter à l'échelon national et international.
Skymab Biotherapeutics is a CEA* spin-off biotech company committed to the design, engineering and development of antibodies targeting G Protein Coupled Receptors (GPCR) with a main focus in oncology.
The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community.
We are run by distinguished practising scientists. We exist to profit science, not shareholders. We inspire new thinking and support the community of biologists.
